$NURO
NeuroMetrix, Inc.

2023 Q3 Form 10-Q Financial Statement

#000162828023025914 Filed on July 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.203M $1.656M
YoY Change -38.86% -22.57%
Cost Of Revenue $421.4K $536.5K
YoY Change -39.24% -21.81%
Gross Profit $781.8K $1.119M
YoY Change -38.66% -22.93%
Gross Profit Margin 64.98% 67.6%
Selling, General & Admin $2.150M $1.989M
YoY Change 12.42% 13.88%
% of Gross Profit 275.02% 177.73%
Research & Development $592.7K $753.5K
YoY Change -44.87% -17.72%
% of Gross Profit 75.81% 67.32%
Depreciation & Amortization $10.00K $10.22K
YoY Change -22.42% -23.73%
% of Gross Profit 1.28% 0.91%
Operating Expenses $2.743M $2.743M
YoY Change -8.19% 3.01%
Operating Profit -$1.961M -$1.623M
YoY Change 14.47% 34.13%
Interest Expense $30.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net $170.0K $86.43K
YoY Change 59.27% 71.49%
Pretax Income -$1.770M -$1.537M
YoY Change 10.19% 32.51%
Income Tax
% Of Pretax Income
Net Earnings -$1.769M -$1.537M
YoY Change 10.12% 32.51%
Net Earnings / Revenue -147.01% -92.83%
Basic Earnings Per Share -$0.21 -$0.19
Diluted Earnings Per Share -$0.21 -$0.19
COMMON SHARES
Basic Shares Outstanding 8.580M shares 7.840M shares
Diluted Shares Outstanding 8.520M shares 7.886M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.64M $19.63M
YoY Change -15.3% -14.55%
Cash & Equivalents $1.461M $1.863M
Short-Term Investments $16.18M $17.76M
Other Short-Term Assets $790.0K $331.5K
YoY Change -6.58% 37.18%
Inventory $1.667M $1.584M
Prepaid Expenses
Receivables $614.4K $746.7K
Other Receivables $0.00 $0.00
Total Short-Term Assets $20.71M $22.29M
YoY Change -11.64% -9.49%
LONG-TERM ASSETS
Property, Plant & Equipment $272.8K $457.7K
YoY Change 55.16% 155.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $26.40K $26.40K
YoY Change 0.0% 0.0%
Total Long-Term Assets $581.1K $484.1K
YoY Change -3.21% -23.17%
TOTAL ASSETS
Total Short-Term Assets $20.71M $22.29M
Total Long-Term Assets $581.1K $484.1K
Total Assets $21.29M $22.77M
YoY Change -11.42% -9.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $225.5K $181.5K
YoY Change -58.2% -54.7%
Accrued Expenses $886.5K $1.028M
YoY Change -21.87% -0.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.260M $1.210M
YoY Change -31.22% -23.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $120.0K $152.1K
YoY Change -48.65% -41.24%
Total Long-Term Liabilities $120.0K $152.1K
YoY Change -48.65% -41.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.260M $1.210M
Total Long-Term Liabilities $120.0K $152.1K
Total Liabilities $1.383M $1.362M
YoY Change -33.05% -26.23%
SHAREHOLDERS EQUITY
Retained Earnings -$208.5M -$206.7M
YoY Change 2.75% 2.69%
Common Stock $859.00 $858.00
YoY Change 20.31% 20.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.90M $21.41M
YoY Change
Total Liabilities & Shareholders Equity $21.29M $22.77M
YoY Change -11.42% -9.83%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.769M -$1.537M
YoY Change 10.12% 32.51%
Depreciation, Depletion And Amortization $10.00K $10.22K
YoY Change -22.42% -23.73%
Cash From Operating Activities -$2.060M -$1.451M
YoY Change -7.53% 73.1%
INVESTING ACTIVITIES
Capital Expenditures $140.0K $0.00
YoY Change -1535.9% -100.0%
Acquisitions
YoY Change
Other Investing Activities $1.800M $237.3K
YoY Change -190.32% -101.4%
Cash From Investing Activities $1.660M $237.3K
YoY Change -182.89% -101.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 700.1K
YoY Change 8841.51%
NET CHANGE
Cash From Operating Activities -2.060M -1.451M
Cash From Investing Activities 1.660M 237.3K
Cash From Financing Activities 0.000 700.1K
Net Change In Cash -400.0K -513.7K
YoY Change -90.54% -97.11%
FREE CASH FLOW
Cash From Operating Activities -$2.060M -$1.451M
Capital Expenditures $140.0K $0.00
Free Cash Flow -$2.200M -$1.451M
YoY Change -0.81% 74.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Cost Of Revenue
CostOfRevenue
1194995 usd
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
16864707 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
646771 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1614987 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
645502 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
24106987 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
165619 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
370609 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26400 usd
CY2022Q4 us-gaap Assets
Assets
24669615 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
368082 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
589939 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
148391 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1106412 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
207516 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1313928 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8578800 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7771938 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
777 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
226934775 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-203579866 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23355687 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24669615 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4440692 usd
us-gaap Gross Profit
GrossProfit
3245697 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1626376 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1425437 usd
us-gaap Operating Expenses
OperatingExpenses
5418005 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2172308 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
50395 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
222321 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1159923 usd
us-gaap Net Income Loss
NetIncomeLoss
-3111203 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1537029 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1159923 usd
us-gaap Net Income Loss
NetIncomeLoss
-3111203 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
102847 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
168721 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1434182 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1159923 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2942482 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2118485 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23355687 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
165361 usd
CY2023Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
65874 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1574174 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
22012748 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
132745 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
691405 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8715 usd
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
102847 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1537029 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
21411431 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23215786 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37632 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1943052 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-958562 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
109340 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
7829 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
215417 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1159923 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
23410571 usd
us-gaap Profit Loss
ProfitLoss
-3111203 usd
us-gaap Profit Loss
ProfitLoss
-2118485 usd
us-gaap Depreciation
Depreciation
20444 usd
us-gaap Depreciation
Depreciation
26277 usd
us-gaap Share Based Compensation
ShareBasedCompensation
298106 usd
us-gaap Share Based Compensation
ShareBasedCompensation
146972 usd
nuro Compensation Obligation Settlement
CompensationObligationSettlement
0 usd
nuro Compensation Obligation Settlement
CompensationObligationSettlement
26019 usd
us-gaap Inventory Write Down
InventoryWriteDown
63420 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-6875 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
131127 usd
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
37275 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
99954 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
236957 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32418 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
162825 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-256729 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-219331 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-186620 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
116536 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
350137 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
465850 usd
nuro Increase Decreasein Accrued Product Returns
IncreaseDecreaseinAccruedProductReturns
0 usd
nuro Increase Decreasein Accrued Product Returns
IncreaseDecreaseinAccruedProductReturns
-31000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2572486 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1578682 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
16928542 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
16599705 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
16000000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13432 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-599705 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16941974 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
700120 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1950881 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
700120 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1950881 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2472071 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16569775 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4335020 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22572104 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1862949 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6002329 usd
CY2023Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
19600000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
25000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7788032 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6937976 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6937976 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</span></div>
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
102847 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
168721 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1537029 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1159923 usd
us-gaap Net Income Loss
NetIncomeLoss
-3111203 usd
us-gaap Net Income Loss
NetIncomeLoss
-2118485 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7885752 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7885752 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6995959 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6995959 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7788032 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
721349 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
804664 shares
CY2023Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
995834 usd
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
995608 usd
CY2022Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
16864707 usd
CY2022Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
16794874 usd
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
16599705 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
178241 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9520 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
16768426 usd
CY2023Q2 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
17873502 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1551027 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1075707 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
982129 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
508278 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
632858 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1583985 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1614987 usd
us-gaap Inventory Write Down
InventoryWriteDown
63420 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
238000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
155000 usd
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
456555 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
249224 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
13000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
16700 usd
CY2023Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
128353 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
131621 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
44168 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
37394 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
880076 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
589939 usd
CY2022Q1 nuro Rent Expense Reduction
RentExpenseReduction
60000 usd
us-gaap Sublease Income
SubleaseIncome
22795 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
82892 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
165785 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
117431 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
366108 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.15
CY2023Q2 nuro Operating Lease Discount
OperatingLeaseDiscount
65574 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
148391 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
152143 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
366108 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
49232 usd
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
46102 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
98464 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
70856 usd
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2022Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
20000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
104200 usd

Files In Submission

Name View Source Status
0001628280-23-025914-index-headers.html Edgar Link pending
0001628280-23-025914-index.html Edgar Link pending
0001628280-23-025914.txt Edgar Link pending
0001628280-23-025914-xbrl.zip Edgar Link pending
a10q63023exhibit311.htm Edgar Link pending
a10q63023exhibit312.htm Edgar Link pending
a10q63023exhibit32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nuro-20230630.htm Edgar Link pending
nuro-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nuro-20230630_def.xml Edgar Link unprocessable
nuro-20230630_lab.xml Edgar Link unprocessable
nuro-20230630_pre.xml Edgar Link unprocessable
nuro-20230630_htm.xml Edgar Link completed
nuro-20230630_cal.xml Edgar Link unprocessable